2022 Revenues ($USD) : $2,922,500,000
2022 R&D spend : $92,700,000
2022 Number of Employees : 12,000
Fiscal Year End : 10/31/2021
Company CEO : Albert White, CEO and president

Cooper Cos. has two business units — CooperVision and CooperSurgical — that provide products and services to advance vision care and women's health. CooperVision is a significant manufacturer of contact lenses, while CooperSurgical’s portfolio focuses on women’s health, fertility and diagnostics. The company purchased fertility services provider Generate Life Sciences for $1.6 billion in December 2021 and added it to the CooperSurgical portfolio. In March 2022, Cooper launched its SightGlass Vision joint venture with EssilorLuxottica. In February, Cooper announced an $875 million deal to buy Cook Medical’s Reproductive Health business. Subject to regulatory approval, that deal is expected to close by the end of the year. – CN and JH